HEADER TRANSFERASE 18-MAR-16 5IUI TITLE CRYSTAL STRUCTURE OF ANAPLASTIC LYPHOMA KINASE (ALK) IN COMPLEX WITH 4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK TYROSINE KINASE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1084-1410; COMPND 5 SYNONYM: ANAPLASTIC LYMPHOMA KINASE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PBAKPAK-8 KEYWDS CATALYTIC DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.H.TU,S.Y.WU REVDAT 3 20-MAR-24 5IUI 1 REMARK REVDAT 2 19-FEB-20 5IUI 1 JRNL REMARK REVDAT 1 18-MAY-16 5IUI 0 JRNL AUTH C.H.TU,W.H.LIN,Y.H.PENG,T.HSU,J.S.WU,C.Y.CHANG,C.T.LU, JRNL AUTH 2 P.C.LYU,C.SHIH,W.T.JIAANG,S.Y.WU JRNL TITL PYRAZOLYLAMINE DERIVATIVES REVEAL THE CONFORMATIONAL JRNL TITL 2 SWITCHING BETWEEN TYPE I AND TYPE II BINDING MODES OF JRNL TITL 3 ANAPLASTIC LYMPHOMA KINASE (ALK). JRNL REF J.MED.CHEM. V. 59 3906 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27031565 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00106 REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 25760 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1285 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 23.6314 - 3.9000 0.95 2802 142 0.1735 0.1907 REMARK 3 2 3.9000 - 3.0978 0.97 2728 133 0.1714 0.1959 REMARK 3 3 3.0978 - 2.7068 0.98 2729 148 0.1743 0.2016 REMARK 3 4 2.7068 - 2.4596 0.98 2687 163 0.1708 0.1911 REMARK 3 5 2.4596 - 2.2835 0.99 2729 124 0.1664 0.1895 REMARK 3 6 2.2835 - 2.1490 0.99 2717 132 0.1847 0.2169 REMARK 3 7 2.1490 - 2.0414 0.99 2696 148 0.1900 0.2483 REMARK 3 8 2.0414 - 1.9526 0.99 2708 157 0.2077 0.2336 REMARK 3 9 1.9526 - 1.8774 0.98 2679 138 0.2622 0.2943 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.950 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2470 REMARK 3 ANGLE : 1.016 3357 REMARK 3 CHIRALITY : 0.036 364 REMARK 3 PLANARITY : 0.005 437 REMARK 3 DIHEDRAL : 14.099 927 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5IUI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1000219304. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL12B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25807 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.880 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.47300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 2000 MME, 0.1M TRIS-HCL PH REMARK 280 8.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.92550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.50850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.71600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.50850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.92550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.71600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 1084 REMARK 465 THR A 1085 REMARK 465 SER A 1086 REMARK 465 THR A 1087 REMARK 465 ILE A 1088 REMARK 465 MET A 1138 REMARK 465 PRO A 1139 REMARK 465 ASN A 1140 REMARK 465 ASP A 1141 REMARK 465 SER A 1281 REMARK 465 TYR A 1282 REMARK 465 TYR A 1283 REMARK 465 ARG A 1284 REMARK 465 LYS A 1285 REMARK 465 TYR A 1401 REMARK 465 GLY A 1402 REMARK 465 PRO A 1403 REMARK 465 LEU A 1404 REMARK 465 VAL A 1405 REMARK 465 GLU A 1406 REMARK 465 GLU A 1407 REMARK 465 GLU A 1408 REMARK 465 GLU A 1409 REMARK 465 LYS A 1410 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A1092 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A1109 CG CD CE NZ REMARK 470 HIS A1124 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A1217 CG CD OE1 NE2 REMARK 470 MET A1302 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1759 O HOH A 1769 2.05 REMARK 500 O HOH A 1626 O HOH A 1775 2.05 REMARK 500 O HOH A 1734 O HOH A 1740 2.10 REMARK 500 O HOH A 1685 O HOH A 1772 2.11 REMARK 500 SG CYS A 1235 O HOH A 1764 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1093 64.43 39.01 REMARK 500 VAL A1155 51.20 -91.60 REMARK 500 GLN A1217 63.79 -109.94 REMARK 500 ARG A1248 -3.09 70.23 REMARK 500 ASP A1249 45.79 -153.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 45Q A 1501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5IUG RELATED DB: PDB REMARK 900 RELATED ID: 5IUH RELATED DB: PDB DBREF 5IUI A 1084 1410 UNP Q9UM73 ALK_HUMAN 1084 1410 SEQADV 5IUI SER A 1097 UNP Q9UM73 CYS 1097 ENGINEERED MUTATION SEQRES 1 A 327 ARG THR SER THR ILE MET THR ASP TYR ASN PRO ASN TYR SEQRES 2 A 327 SER PHE ALA GLY LYS THR SER SER ILE SER ASP LEU LYS SEQRES 3 A 327 GLU VAL PRO ARG LYS ASN ILE THR LEU ILE ARG GLY LEU SEQRES 4 A 327 GLY HIS GLY ALA PHE GLY GLU VAL TYR GLU GLY GLN VAL SEQRES 5 A 327 SER GLY MET PRO ASN ASP PRO SER PRO LEU GLN VAL ALA SEQRES 6 A 327 VAL LYS THR LEU PRO GLU VAL CYS SER GLU GLN ASP GLU SEQRES 7 A 327 LEU ASP PHE LEU MET GLU ALA LEU ILE ILE SER LYS PHE SEQRES 8 A 327 ASN HIS GLN ASN ILE VAL ARG CYS ILE GLY VAL SER LEU SEQRES 9 A 327 GLN SER LEU PRO ARG PHE ILE LEU LEU GLU LEU MET ALA SEQRES 10 A 327 GLY GLY ASP LEU LYS SER PHE LEU ARG GLU THR ARG PRO SEQRES 11 A 327 ARG PRO SER GLN PRO SER SER LEU ALA MET LEU ASP LEU SEQRES 12 A 327 LEU HIS VAL ALA ARG ASP ILE ALA CYS GLY CYS GLN TYR SEQRES 13 A 327 LEU GLU GLU ASN HIS PHE ILE HIS ARG ASP ILE ALA ALA SEQRES 14 A 327 ARG ASN CYS LEU LEU THR CYS PRO GLY PRO GLY ARG VAL SEQRES 15 A 327 ALA LYS ILE GLY ASP PHE GLY MET ALA ARG ASP ILE TYR SEQRES 16 A 327 ARG ALA SER TYR TYR ARG LYS GLY GLY CYS ALA MET LEU SEQRES 17 A 327 PRO VAL LYS TRP MET PRO PRO GLU ALA PHE MET GLU GLY SEQRES 18 A 327 ILE PHE THR SER LYS THR ASP THR TRP SER PHE GLY VAL SEQRES 19 A 327 LEU LEU TRP GLU ILE PHE SER LEU GLY TYR MET PRO TYR SEQRES 20 A 327 PRO SER LYS SER ASN GLN GLU VAL LEU GLU PHE VAL THR SEQRES 21 A 327 SER GLY GLY ARG MET ASP PRO PRO LYS ASN CYS PRO GLY SEQRES 22 A 327 PRO VAL TYR ARG ILE MET THR GLN CYS TRP GLN HIS GLN SEQRES 23 A 327 PRO GLU ASP ARG PRO ASN PHE ALA ILE ILE LEU GLU ARG SEQRES 24 A 327 ILE GLU TYR CYS THR GLN ASP PRO ASP VAL ILE ASN THR SEQRES 25 A 327 ALA LEU PRO ILE GLU TYR GLY PRO LEU VAL GLU GLU GLU SEQRES 26 A 327 GLU LYS HET 45Q A1501 30 HETNAM 45Q N-[3-(4-AMINO-3-METHYLPHENYL)-1H-PYRAZOL-5-YL]-4-[(4- HETNAM 2 45Q METHYLPIPERAZIN-1-YL)METHYL]BENZAMIDE FORMUL 2 45Q C23 H28 N6 O FORMUL 3 HOH *186(H2 O) HELIX 1 AA1 SER A 1106 LEU A 1108 5 3 HELIX 2 AA2 PRO A 1112 LYS A 1114 5 3 HELIX 3 AA3 SER A 1157 PHE A 1174 1 18 HELIX 4 AA4 LEU A 1204 THR A 1211 1 8 HELIX 5 AA5 ALA A 1222 ASN A 1243 1 22 HELIX 6 AA6 ALA A 1251 ARG A 1253 5 3 HELIX 7 AA7 PHE A 1271 ARG A 1279 1 9 HELIX 8 AA8 GLY A 1287 LEU A 1291 5 5 HELIX 9 AA9 PRO A 1292 MET A 1296 5 5 HELIX 10 AB1 PRO A 1297 MET A 1302 1 6 HELIX 11 AB2 THR A 1307 SER A 1324 1 18 HELIX 12 AB3 SER A 1334 SER A 1344 1 11 HELIX 13 AB4 PRO A 1355 TRP A 1366 1 12 HELIX 14 AB5 GLN A 1369 ARG A 1373 5 5 HELIX 15 AB6 ASN A 1375 ASP A 1389 1 15 HELIX 16 AB7 ASP A 1389 ASN A 1394 1 6 SHEET 1 AA1 2 ASN A1095 PHE A1098 0 SHEET 2 AA1 2 LYS A1101 SER A1104 -1 O SER A1103 N TYR A1096 SHEET 1 AA2 5 ILE A1116 GLY A1121 0 SHEET 2 AA2 5 VAL A1130 VAL A1135 -1 O GLU A1132 N ILE A1119 SHEET 3 AA2 5 LEU A1145 LEU A1152 -1 O VAL A1149 N TYR A1131 SHEET 4 AA2 5 ARG A1192 GLU A1197 -1 O LEU A1196 N ALA A1148 SHEET 5 AA2 5 CYS A1182 SER A1186 -1 N GLY A1184 O LEU A1195 SHEET 1 AA3 3 GLY A1202 ASP A1203 0 SHEET 2 AA3 3 CYS A1255 LEU A1257 -1 O LEU A1257 N GLY A1202 SHEET 3 AA3 3 ALA A1266 ILE A1268 -1 O LYS A1267 N LEU A1256 CISPEP 1 LEU A 1190 PRO A 1191 0 -3.18 SITE 1 AC1 11 PHE A1127 ALA A1148 LYS A1150 LEU A1196 SITE 2 AC1 11 GLU A1197 MET A1199 ALA A1200 GLY A1201 SITE 3 AC1 11 LEU A1256 GLY A1269 HOH A1608 CRYST1 51.851 57.432 105.017 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019286 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017412 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009522 0.00000